BR112013032857A2 - método para prever a resposta clínica à quimioterapia em um indivíduo com câncer - Google Patents
método para prever a resposta clínica à quimioterapia em um indivíduo com câncerInfo
- Publication number
- BR112013032857A2 BR112013032857A2 BR112013032857A BR112013032857A BR112013032857A2 BR 112013032857 A2 BR112013032857 A2 BR 112013032857A2 BR 112013032857 A BR112013032857 A BR 112013032857A BR 112013032857 A BR112013032857 A BR 112013032857A BR 112013032857 A2 BR112013032857 A2 BR 112013032857A2
- Authority
- BR
- Brazil
- Prior art keywords
- chemotherapy
- cancer
- individual
- clinical response
- predict clinical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
- G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11382211 | 2011-06-20 | ||
| US201161507833P | 2011-07-14 | 2011-07-14 | |
| EP11382294 | 2011-09-16 | ||
| PCT/EP2012/061790 WO2012175537A1 (en) | 2011-06-20 | 2012-06-20 | Method for predicting the clinical response to chemotherapy in a subject with cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013032857A2 true BR112013032857A2 (pt) | 2017-01-24 |
Family
ID=47422050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013032857A BR112013032857A2 (pt) | 2011-06-20 | 2012-06-20 | método para prever a resposta clínica à quimioterapia em um indivíduo com câncer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150004252A1 (https=) |
| EP (1) | EP2721174A1 (https=) |
| JP (1) | JP2014527397A (https=) |
| KR (1) | KR20140047664A (https=) |
| CN (1) | CN103687964A (https=) |
| AU (1) | AU2012274156A1 (https=) |
| BR (1) | BR112013032857A2 (https=) |
| CA (1) | CA2840129A1 (https=) |
| MX (1) | MX2013015286A (https=) |
| RU (1) | RU2014101492A (https=) |
| WO (1) | WO2012175537A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017083739A1 (en) * | 2015-11-13 | 2017-05-18 | The Trustees Of Columbia University In The City Of New York | A method for predicting a subject's response to valproic acid therapy |
| US20170305861A1 (en) * | 2016-04-25 | 2017-10-26 | Immunomet Therapeutics, Inc | Heteroaryl compounds comprising nitrogen and use thereof |
| US10683292B2 (en) * | 2016-07-25 | 2020-06-16 | Nerviano Medical Sciences S.R.L. | Purine and 3-deazapurine analogues as choline kinase inhibitors |
| WO2018177326A1 (en) * | 2017-03-29 | 2018-10-04 | Crown Bioscience Inc. (Taicang) | System and method for determining karenitecin sensitivity on cancer |
| CN107050668B (zh) * | 2017-06-09 | 2020-03-31 | 南京医科大学第一附属医院 | 基于云处理的放疗效果预测方法 |
| EP3502700A1 (en) * | 2017-12-21 | 2019-06-26 | Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron | Methods based on the detection of rad51 foci in tumor cells |
| CN116859058A (zh) * | 2023-07-17 | 2023-10-10 | 上海中医药大学 | 一种基于NDR1-Myc互作抗结直肠癌活性分子筛选方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22545A1 (es) | 1994-11-18 | 1999-03-31 | Centro Inmunologia Molecular | Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico |
| US4943533A (en) | 1984-03-01 | 1990-07-24 | The Regents Of The University Of California | Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor |
| EP0491007B1 (en) | 1989-09-08 | 1996-03-13 | The Johns Hopkins University | Structural alterations of the egf receptor gene in human gliomas |
| JPH11507535A (ja) | 1995-06-07 | 1999-07-06 | イムクローン システムズ インコーポレイテッド | 腫瘍の成長を抑制する抗体および抗体フラグメント類 |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| ES2237332B1 (es) | 2004-01-14 | 2006-11-01 | Consejo Sup. Investig. Cientificas | Derivados de piridinio y quinolinio. |
| WO2006108905A1 (es) * | 2005-04-13 | 2006-10-19 | Consejo Superior De Investigaciones Científicas | Método in vitro para identificar compuestos para terapia del cáncer |
| GB0519405D0 (en) * | 2005-09-23 | 2005-11-02 | Univ Aberdeen | Cancer therapy prognosis and target |
| RU2509809C2 (ru) * | 2008-07-04 | 2014-03-20 | Транслэшионал Кэнсэр Драгз Фарма, С.Л. | Способы лечения и диагностики рака |
| US9896720B2 (en) | 2008-09-10 | 2018-02-20 | Rutgers, The State University Of New Jersey | Imaging individual mRNA molecules using multiple singly labeled probes |
| US20100068302A1 (en) | 2008-09-17 | 2010-03-18 | Traslational Cancer Drugs Pharma, S.L. | Methods and compositions for the treatment of cancer |
-
2012
- 2012-06-20 JP JP2014516320A patent/JP2014527397A/ja active Pending
- 2012-06-20 BR BR112013032857A patent/BR112013032857A2/pt not_active IP Right Cessation
- 2012-06-20 CN CN201280035399.6A patent/CN103687964A/zh active Pending
- 2012-06-20 CA CA2840129A patent/CA2840129A1/en not_active Abandoned
- 2012-06-20 AU AU2012274156A patent/AU2012274156A1/en not_active Abandoned
- 2012-06-20 EP EP12730874.0A patent/EP2721174A1/en not_active Withdrawn
- 2012-06-20 RU RU2014101492/10A patent/RU2014101492A/ru not_active Application Discontinuation
- 2012-06-20 KR KR1020147001560A patent/KR20140047664A/ko not_active Withdrawn
- 2012-06-20 US US14/128,369 patent/US20150004252A1/en not_active Abandoned
- 2012-06-20 MX MX2013015286A patent/MX2013015286A/es not_active Application Discontinuation
- 2012-06-20 WO PCT/EP2012/061790 patent/WO2012175537A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012175537A1 (en) | 2012-12-27 |
| CA2840129A1 (en) | 2012-12-27 |
| EP2721174A1 (en) | 2014-04-23 |
| RU2014101492A (ru) | 2015-07-27 |
| JP2014527397A (ja) | 2014-10-16 |
| KR20140047664A (ko) | 2014-04-22 |
| US20150004252A1 (en) | 2015-01-01 |
| CN103687964A (zh) | 2014-03-26 |
| AU2012274156A1 (en) | 2014-01-23 |
| MX2013015286A (es) | 2014-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013032559A2 (pt) | cookie em camads saudável | |
| BR112013030354A2 (pt) | método implementado por computador | |
| BR112013032502A2 (pt) | propagandas em vizualização | |
| IL232257A0 (en) | Personal aircraft | |
| EP2774205A4 (en) | CELL WITH INTERNAL CONVECTION | |
| EP2696815A4 (en) | STENTS WITH TAXED ELUTION | |
| EP2718374A4 (en) | CORE CASE MICRO BALLS | |
| BR302012003138S1 (pt) | Configuração aplicada em relógio | |
| PT2726919T (pt) | Um painel seletivo em termos espetrais | |
| IL236777B (en) | Method and system for prediction of crowd formation | |
| BR112014011318A2 (pt) | empresa de computação | |
| CO6880052A2 (es) | Panel antibalístico | |
| DK3219801T3 (da) | Konstruktion | |
| FI20115270L (fi) | Lentolaite | |
| BR112013030065A2 (pt) | computador e método de controle de computador | |
| BR112013032857A2 (pt) | método para prever a resposta clínica à quimioterapia em um indivíduo com câncer | |
| IL227914A0 (en) | Keypad | |
| IL228636A0 (en) | Biomarkers for predicting sensitivity to cancer treatments | |
| FI20115227L (fi) | Double click-teknologia | |
| BRDI7105933S (pt) | Configuração aplicada em painel para aeronave | |
| BR112013030248A2 (pt) | aeronave | |
| DK2681530T3 (da) | Gennemstrømmelig målecelle | |
| EP2748432A4 (en) | SELF DRILLING TUBE ANCHOR | |
| BR112013020332A2 (pt) | guia deformável para divisórias em geral | |
| PL2560406T3 (pl) | Układ interfejsu oraz system z układem interfejsu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |